tiprankstipranks
Trending News
More News >
Alterola Biotech (ABTI)
OTHER OTC:ABTI
US Market

Alterola Biotech (ABTI) Income Statement

Compare
10 Followers

Alterola Biotech Income Statement

Last quarter (Q2 2024), Alterola Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Alterola Biotech's net income was $-123.16K. See Alterola Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Sep 20Sep 19Sep 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.70M$ 6.47M$ 329.51K$ 258.45K$ 122.56K
Depreciation and Amortization
$ 200.00K$ 0.00$ 79.00K$ 206.30K$ 171.86K
EBITDA
$ -1.70M$ -6.47M$ -250.51K$ -258.45K$ -122.56K
Operating Income
$ -1.90M$ -6.47M$ -329.51K$ -258.45K$ -122.56K
Other Income/Expenses
$ 200.00K$ 0.00$ 79.00K$ -249.00$ -10.51K
Pretax Income
$ -1.70M$ -6.47M$ -250.51K$ -258.70K$ -133.07K
Net Income
$ -1.54M$ -6.47M$ -171.51K$ -258.70K$ -133.07K
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ -0.01$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
806.33M 769.97M 118.06M 116.56M 115.62M
Weighted Average Shares Outstanding (Diluted)
806.33M 769.97M 118.06M 116.56M 115.62M
Currency in USD

Alterola Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis